Role of Endoscopic Therapy Plus Intravenous Proton Pump Inhibitor in Uremic Patients with High-Risk Peptic Ulcer Bleeding. Preliminary Report of a Case-Controlled Study

2009 ◽  
Vol 69 (5) ◽  
pp. AB179-AB180
Author(s):  
Gaun-Ying Tseng
2012 ◽  
pp. 5-11
Author(s):  
Ngoc Quy Hue Dang ◽  
Van Huy Tran

Peptic ulcer bleeding is a common medical emergency and still a potentially fatal condition. It is the best managed using a multidisciplinary approach by a team with medical, endoscopic and surgical expertise. Appropriate resuscitation followed by early endoscopy for diagnosis and treatment are of major importance in these patients. Endoscopy is recommended within 24 h of presentation. Endoscopic therapy is indicated for patients with high-risk stigmata, in particular those with active bleeding and visible vessels. A combination of proton pump inhibitors and endoscopic therapy (using a combination of injection and mechanical hemostasis) offers the best chance of hemostasis for those with active bleeding ulcers. The application of an ulcer-covering hemospray is a new promising tool. High dose proton pump inhibitors should be administered intravenously for 72 h in high-risk patients. Helicobacter pylori should be tested for in all patients with peptic ulcer bleeding and eradicated if positive


2012 ◽  
Vol 27 (9) ◽  
pp. 1473-1479 ◽  
Author(s):  
Na Liu ◽  
Lili Liu ◽  
HongBo Zhang ◽  
Prakash Chandra Gyawali ◽  
Dexin Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document